Panzara Michael A.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Panzara Michael A.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| WVE | See Remarks | Award / Grant | 50,000 | — | — | May 5, 2022 |
| WVE | See Remarks | Sale | 10,603 | $2.31 | $24,493 | Feb 16, 2022 |
| WVE | See Remarks | Sale | 2,929 | $10.57 | $30,960 | Feb 1, 2021 |
| WVE | Chief Medical Officer | Sale | 2,981 | $7.85 | $23,401 | Feb 18, 2020 |
| WVE | Chief Medical Officer | Sale | 2,613 | $26.88 | $70,237 | Jul 5, 2019 |
| WVE | Franchise Lead, Neurology | Award / Grant | 15,000 | — | — | Mar 11, 2019 |
| WVE | Franchise Lead, Neurology | Sale | 1,837 | $36.84 | $67,675 | Feb 19, 2019 |
| WVE | Franchise Lead, Neurology | Sale | 511 | $52.10 | $26,623 | Feb 16, 2018 |
| WVE | Franchise Lead, Neurology | Sale | 18,750 | $50.00 | $937,500 | Feb 15, 2018 |
| WVE | Franchise Lead, Neurology | Award / Grant | 17,500 | — | — | Jan 23, 2018 |
| WVE | Franchise Lead, Neurology | Sale | 7,414 | $16.67 | $123,591 | Jul 12, 2017 |
| WVE | Head of Neurology Franchise | Award / Grant | 6,900 | — | — | Jan 25, 2017 |
| WVE | Franchise Lead, Neurology | Award / Grant | 22,750 | — | — | Jul 11, 2016 |